Company intelligence / Profile preview

SciGen Ltd

Singapore, Singaporescigen.com ↗
Ownership
Private
Employees
~50
Development stage
Commercial
01

Overview

SciGen Ltd is a Singapore-based biopharmaceutical company specializing in the development, manufacturing, marketing, and commercialization of innovative healthcare products—primarily biosimilar biologics and medical devices. The company's portfolio covers endocrinology, oncology, immunology and related fields. It has a global commercial presence with operations across Asia-Pacific and product registrations worldwide. In recent years it has expanded through acquisition of established brands/products from major pharma companies.

Therapeutic areas
OncologyEndocrinologyRheumatologyHematology
Modalities
Recombinant proteins/biologics (e.g., recombinant human insulin, growth hormone)BiosimilarsMedical devices
Industry
Biotech
02

Drug pipeline

4 assets

SciTropin A

Commercial
Indications
Growth hormone deficiency

3 more assets in the full pipeline.

03

Partnerships

Partnerships with regional distributors across Asia-Pacificjoint ventures for manufacturing in China with Hefei Life Science & Technology Investments & Development Park and Bioton S.A.previously partnered with Novartis for Zometa® acquisition.

Beyond the preview

Go deeper on SciGen Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SciGen Ltd.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call